Literature DB >> 33441583

Leishmania donovani infection suppresses Allograft Inflammatory Factor-1 in monocytes and macrophages to inhibit inflammatory responses.

Ricardo Louzada da Silva1,2, Diana M Elizondo1,3, Nailah Z D Brandy1, Naomi L Haddock1,4, Thomas A Boddie1, Laís Lima de Oliveira2, Amélia Ribeiro de Jesus2, Roque Pacheco de Almeida2, Tatiana Rodrigues de Moura2, Michael W Lipscomb5.   

Abstract

Macrophages and monocytes are important for clearance of Leishmania infections. However, immune evasion tactics employed by the parasite results in suppressed inflammatory responses, marked by deficient macrophage functions and increased accumulation of monocytes. This results in an ineffective ability to clear parasite loads. Allograft Inflammatory Factor-1 (AIF1) is expressed in myeloid cells and serves to promote immune responses. However, AIF1 involvement in monocyte and macrophage functions during parasitic infections has not been explored. This study now shows that Leishmania donovani inhibits AIF1 expression in macrophages to block pro-inflammatory responses. Mice challenged with the parasite had markedly reduced AIF1 expression in splenic macrophages. Follow-up studies using in vitro approaches confirmed that L. donovani infection in macrophages suppresses AIF1 expression, which correlated with reduction in pro-inflammatory cytokine production and increased parasite load. Ectopic overexpression of AIF1 in macrophages provided protection from infection, marked by robust pro-inflammatory cytokine production and efficient pathogen clearance. Further investigations found that inhibiting AIF1 expression in bone marrow cells or monocytes impaired differentiation into functional macrophages. Collectively, results show that AIF1 is a critical regulatory component governing monocyte and macrophage immune functions and that L. donovani infection can suppress the gene as an immune evasion tactic.

Entities:  

Year:  2021        PMID: 33441583      PMCID: PMC7807085          DOI: 10.1038/s41598-020-79068-6

Source DB:  PubMed          Journal:  Sci Rep        ISSN: 2045-2322            Impact factor:   4.379


  39 in total

1.  Allograft inflammatory factor-1 (AIF-1) is crucial for the survival and pro-inflammatory activity of macrophages.

Authors:  Zhen Fan Yang; David W Ho; Chi Keung Lau; Chi Tat Lam; Ching Tung Lum; Ronnie T P Poon; Sheung Tat Fan
Journal:  Int Immunol       Date:  2005-09-12       Impact factor: 4.823

2.  Role of allograft inflammatory factor-1 in the regulation of inflammation and oxidative stress in primary peritoneal mesothelial cells.

Authors:  Yinan Zhou; Xin Li; Xueying Yuan; Lirong Hao
Journal:  Cell Biol Int       Date:  2019-03-12       Impact factor: 3.612

3.  Leishmania donovani infection of bone marrow stromal macrophages selectively enhances myelopoiesis, by a mechanism involving GM-CSF and TNF-alpha.

Authors:  S E Cotterell; C R Engwerda; P M Kaye
Journal:  Blood       Date:  2000-03-01       Impact factor: 22.113

4.  General suppression of macrophage gene expression during Leishmania donovani infection.

Authors:  S Buates; G Matlashewski
Journal:  J Immunol       Date:  2001-03-01       Impact factor: 5.422

5.  Colony-stimulating factor-1-induced AIF1 expression in tumor-associated macrophages enhances the progression of hepatocellular carcinoma.

Authors:  Hao Cai; Xiao-Dong Zhu; Jian-Yang Ao; Bo-Gen Ye; Yuan-Yuan Zhang; Zong-Tao Chai; Cheng-Hao Wang; Wen-Kai Shi; Man-Qing Cao; Xiao-Long Li; Hui-Chuan Sun
Journal:  Oncoimmunology       Date:  2017-05-26       Impact factor: 8.110

6.  Involvement of Iba1 in membrane ruffling and phagocytosis of macrophages/microglia.

Authors:  K Ohsawa; Y Imai; H Kanazawa; Y Sasaki; S Kohsaka
Journal:  J Cell Sci       Date:  2000-09       Impact factor: 5.285

7.  Direct visualization of peptide/MHC complexes at the surface and in the intracellular compartments of cells infected in vivo by Leishmania major.

Authors:  Eric Muraille; Pierre Gounon; Julie Cazareth; Johan Hoebeke; Christoph Lippuner; Ana Davalos-Misslitz; Toni Aebischer; Sylviane Muller; Nicolas Glaichenhaus; Evelyne Mougneau
Journal:  PLoS Pathog       Date:  2010-10-14       Impact factor: 6.823

8.  sCD163 levels as a biomarker of disease severity in leprosy and visceral leishmaniasis.

Authors:  Ricardo Luís Louzada Silva; Marcio B Santos; Priscila L S Almeida; Thayse S Barros; Lucas Magalhães; Rodrigo A Cazzaniga; Patrícia R M Souza; Nívea F Luz; Jaqueline França-Costa; Valeria M Borges; Djalma S Lima-Junior; Michael W Lipscomb; Malcolm S Duthie; Steven G Reed; Roque Pacheco Almeida; Amélia Ribeiro Jesus
Journal:  PLoS Negl Trop Dis       Date:  2017-03-29

9.  Allograft Inflammatory Factor-1 Governs Hematopoietic Stem Cell Differentiation Into cDC1 and Monocyte-Derived Dendritic Cells Through IRF8 and RelB in vitro.

Authors:  Diana M Elizondo; Nailah Z D Brandy; Ricardo L L da Silva; Naomi L Haddock; Apollo D Kacsinta; Tatiana R de Moura; Michael W Lipscomb
Journal:  Front Immunol       Date:  2019-02-08       Impact factor: 7.561

10.  CD11c-expressing Ly6C+CCR2+ monocytes constitute a reservoir for efficient Leishmania proliferation and cell-to-cell transmission.

Authors:  Sandrina Heyde; Lars Philipsen; Pauline Formaglio; Yan Fu; Iris Baars; Guido Höbbel; Corinna L Kleinholz; Elena A Seiß; Juliane Stettin; Patricia Gintschel; Anne Dudeck; Philippe Bousso; Burkhart Schraven; Andreas J Müller
Journal:  PLoS Pathog       Date:  2018-10-22       Impact factor: 6.823

View more
  2 in total

1.  Dissection of the macrophage response towards infection by the Leishmania-viral endosymbiont duo and dynamics of the type I interferon response.

Authors:  Amel Bekkar; Nathalie Isorce; Tiia Snäkä; Stéphanie Claudinot; Chantal Desponds; Dmitry Kopelyanskiy; Florence Prével; Marta Reverte; Ioannis Xenarios; Nicolas Fasel; Filipa Teixeira
Journal:  Front Cell Infect Microbiol       Date:  2022-08-04       Impact factor: 6.073

2.  Quantitative proteomics of small numbers of closely-related cells: Selection of the optimal method for a clinical setting.

Authors:  Kyra van der Pan; Sara Kassem; Indu Khatri; Arnoud H de Ru; George M C Janssen; Rayman T N Tjokrodirijo; Fadi Al Makindji; Eftychia Stavrakaki; Anniek L de Jager; Brigitta A E Naber; Inge F de Laat; Alesha Louis; Wouter B L van den Bossche; Lisette B Vogelezang; Rutger K Balvers; Martine L M Lamfers; Peter A van Veelen; Alberto Orfao; Jacques J M van Dongen; Cristina Teodosio; Paula Díez
Journal:  Front Med (Lausanne)       Date:  2022-09-27
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.